SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: seminole who wrote (775)3/16/1998 4:29:00 PM
From: Doug Thatcher  Read Replies (1) of 1826
 
I have been reading this group for the past 6 months. Interesting stuff
although I don't understand everything. I bought 400 shares of
MOGN in early 1991 for $9.125, then sold them for $24 in January
1992. When MGI cancelled testing on that one drug in 1993, I
bought 1700 shares for $10.50; thinking that the market had over-
reacted. I had a sell order in for all of it in September 1993 for $15.50,
but it never quite got there and fell ever since. I still own the stock.
I bought another 700 shares (2500 total) at $4.00 and now have a
blended rate of about $8.50. I'm really not sure what's going to happen now but I'm in for the long run....

I enjoy all your comments...

Doug Thatcher
Seattle
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext